Giant Biogene Holding Co Ltd

02367

Company Profile

  • Business description

    Giant Biogene Holding Co Ltd design, develop and manufacture professional skin treatment products with recombinant collagen as the key bioactive ingredient. The company also develops and manufactures rare ginsenosides technology-based functional foods. The company utilizes proprietary synthetic biology technology to develop and manufacture multiple types of recombinant collagen and rare ginsenosides in-house. Bioactive ingredients offer a wealth of beauty and health properties such as skin repair, anti-aging, whitening, moisturizing and immunity improvement with a broad range of applications in the beauty and health sectors.

  • Contact

    No. 1855, Shanglin Yuan 7th Road
    Chang’an District
    Shaanxi Province
    Xi’an
    CHN

    http://www.xajuzi.com

  • Sector

    Consumer Defensive

    Stock type

    Defensive

  • Industry

    Household & Personal Products

    Fiscal Year End

    31 December 2025

    Employees

    1,512

Stocks News & Analysis

stocks

2 undervalued ASX shares report

These two ASX shares are trading at a discount to our fair value. 
stocks

Turmoil at WiseTech

Board members step down over differences on the role of former CEO Richard White.
video

What does the RBA rate cut mean for investors?

Morningstar's Chief Investment Officer for Asia-Pacific and Director of Personal Finance share their thoughts on the recent RBA rate cut.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,494.5065.60-0.77%
CAC 408,090.9963.52-0.78%
DAX 4022,425.93138.370.62%
Dow JONES (US)43,461.2133.190.08%
FTSE 1008,658.980.39-0.00%
HKSE22,998.69342.92-1.47%
NASDAQ19,286.93237.08-1.21%
Nikkei 22538,345.99430.95-1.11%
NZX 50 Index12,355.74175.98-1.40%
S&P 5005,983.2529.88-0.50%
S&P/ASX 2008,247.0061.20-0.74%
SSE Composite Index3,359.2713.76-0.41%

Market Movers